Changing the Game in
Drug Development and Patient Access

Model-informed Drug Development
Health Economics/Outcomes Research & Real World Evidence
Regulatory Science, Strategy & Services

Certara Launches Version 8.1 of Industry-leading Phoenix PK/PD M&S Software; Introduces Professional Certification Program

Certara Acquires Analytica Laser, a Leader in Market Access, HEOR, and Real-world Evidence Solutions

Certara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018

FDA Renews and Expands its Portfolio of Simcyp Simulator Licenses

Increased Use of PBPK Modeling and Simulation is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments